Elanco Animal Health Stock Performance

Elanco Animal Health Inc. (ticker: ELAN) closed the trading session on Thursday, 22 August 2026, at USD 22.55, reflecting a decline of 0.66 % relative to the previous close. The share price fell to USD 22.55 at 12:01 PM Central Europe time.

Market Overview

ItemValue
Current priceUSD 22.55
Market capitalizationUSD 11.30 bn
Shares outstanding499.6 million
24‑hour volumeUSD 109.60 mn
200‑day simple moving averageUSD 23.82
52‑week highUSD 27.98 (5 August 2026)
52‑week lowUSD 19.40 (19 May 2026)
Month‑end change–1.66 %

The stock’s decline over the last month is consistent with its recent downtrend, and the 200‑day moving average remains above the current price, indicating a short‑term bearish bias.


TickerCurrent Price (USD)% ChangeMarket Cap (USD bn)P/E Ratio
Gamestop (GME)26.29–0.68 %13.4017.06
Carlisle Cos (CSL)340.1+0.09 %13.5019.36
Somnigroup (SGI)62.87–1.67 %13.5025.44
Ares Capital (ARCC)18.40–0.59 %13.2013.82
Bridgebio Pharma (BBIO)67.74+0.28 %13.40–

Key Corporate Actions

Elanco Animal Health

  • Industry focus: Companion and food animal health products.
  • Headquarters: Greenfield, United States.
  • Listing: New York Stock Exchange (ticker: ELAN).
  • IPO: 20 September 2018.

Gamestop (GME)

  • Recent corporate activity: eBay Inc. announced a second round of workforce reductions, cutting roughly 1,000 positions (≈9 %). The cuts follow an earlier 6 % reduction in February.
  • Strategic focus: Concentration on high‑growth segments, including authenticated luxury goods, collectibles, and refurbished items.
  • Recent developments: eBay’s board rejected GameStop’s unsolicited takeover proposal valued at approximately USD 56 bn, citing financing and operational risks.
  • Outlook: eBay’s upcoming earnings report will provide further insight into the impact of the layoffs and cost‑saving trajectory.

Conclusion

Elanco Animal Health’s share price experienced a modest decline during the 24‑hour period ending at 12:01 PM Central Europe time, falling below its 200‑day moving average. The company’s market capitalization and trading volume remain substantial, with a current valuation of USD 11.3 bn. Comparative performance of peer stocks shows a mix of modest gains and losses, reflecting sector‑specific dynamics and recent corporate actions. Investors should monitor upcoming earnings releases and market developments for additional context.